
Plus Therapeutics Raises $15 Million in Private Placement Funding
Plus Therapeutics Secures $15.0 Million in Private Placement Funding for Central Nervous System Cancers HOUSTON, March 04, 2025 β Plus Therapeutics, Inc. (Nasdaq: PSTV), a pioneering clinical-stage pharmaceutical company specializing in the development of targeted radiotherapeutics and advanced platform technologies for central nervous system (CNS) cancers, recently announced the pricing of a private placement. This…